A pan-cancer analysis of ddr1 in prognostic signature and tumor immunity, drug resistance

HIGHLIGHTS

  • who: Longfei Yang from the Medical SchoolNantong University China have published the research work: A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance, in the Journal: Scientific Reports Scientific Reports
  • what: Our first pan-cancer analyses of DDR1 indicate that this factor is differentially expressed between tumor tissues and normal tissues and reveals a correlation of DDR1 with DNA methylation and RNA methylation-related genes.
  • how: As the number of normal samples for some cancers in the TCGA database was limited the authors used data from the GTEx . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?